Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

OBERG JAY K.

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/1/2019

3. Issuer Name and Ticker or Trading Symbol

COMERICA INC /NEW/ [CMA]

(Last) (First) (Middle)

1717 MAIN STREET

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
EVP-Chief Risk Officer /

(Street)

DALLAS, TX 75201

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	26035 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	1/25/2012 ⁽²⁾	1/25/2021	Common Stock	1500	$39.10	D
Employee Stock Option (right to buy)	1/24/2013 ⁽²⁾	1/24/2022	Common Stock	4000	$29.60	D
Employee Stock Option (right to buy)	1/22/2014 ⁽²⁾	1/22/2023	Common Stock	3000	$33.79	D
Employee Stock Option (right to buy)	1/21/2015 ⁽²⁾	1/21/2024	Common Stock	2205	$49.51	D
Employee Stock Option (right to buy)	1/27/2016 ⁽²⁾	1/27/2025	Common Stock	2640	$42.32	D
Employee Stock Option (right to buy)	1/26/2017 ⁽²⁾	1/26/2026	Common Stock	2130	$32.97	D
Employee Stock Option (right to buy)	1/24/2018 ⁽²⁾	1/24/2027	Common Stock	1010	$67.66	D
Employee Stock Option (right to buy)	1/23/2019 ⁽²⁾	1/23/2028	Common Stock	805	$95.25	D

Explanation of Responses:
(1)	Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of January 1, 2019.
(2)	The options vest in four equal annual installments (based on the original grant amount) beginning on the date indicated in this column.

Remarks:
Ex.24 - Power of Attorney for Jay K. Oberg

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
OBERG JAY K. 1717 MAIN STREET DALLAS, TX 75201			EVP-Chief Risk Officer

Signatures
/s/ Jennifer S. Perry, on behalf of Jay K. Oberg through Power of Attorney		1/7/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.